D27: comparing pain treatments (cannabis and non-cannabis)

Here is an expanded response on pain treatments with and without cannabinoids separated into clear header sections for organization:

Over-The-Counter Analgesics

  • Acetaminophen and NSAIDs like ibuprofen and naproxen primarily work by inhibiting cyclooxygenase (COX) enzymes. This reduces synthesis of prostaglandins involved in nociception and inflammation.
  • Acetaminophen is considered a weaker NSAID with less anti-inflammatory effects compared to other OTC NSAIDs.

Opioids

  • Opioids activate mu, kappa and delta receptors in the central and peripheral nervous systems to reduce pain perception and emotional response.
  • Mu receptor activation by drugs like morphine, oxycodone and fentanyl provides powerful analgesia but is also associated with respiratory depression, sedation and abuse liability.

Corticosteroids

  • Corticosteroids diminish inflammation by inhibiting production of inflammatory mediators and stabilizing lysosomal membranes.

Cannabinoids

  • Cannabidiol (CBD) does not directly bind cannabinoid receptors but may inhibit COX-2, reduce neuroinflammation, and act on TRPV1, PPARγ, 5-HT1A and other targets.
  • Tetrahydrocannabinol (THC) binds CB1 and CB2 receptors, activation of which decreases nociception and release of pro-inflammatory cytokines.
  • CB1 receptor activation may also interact synergistically with endogenous opioid systems for enhanced analgesia.

Comparison of Efficacy and Mechanisms

  • Cannabinoids generally provide more potent analgesia along with anti-inflammatory effects through inhibition of cytokine release from immune cells.
  • Cannabinoids offer a similar strength of analgesia to opioids but with a lower risk of dependence and overdose.
  • Like corticosteroids, cannabinoids suppress multiple inflammatory pathways but are safer with chronic use and less systemically toxic.

Citations

Over-The-Counter Analgesics

  1. Sinatra R. Local Anesthetic and Combination Products. J Pain Symptom Manage. 2019 Dec;58(6):e28-e30.
  2. Malhotra R, Tomar R, Dhawan A. Over-the-counter analgesics in pain management. J Postgrad Med. 2018 Apr-Jun;64(2):88-93.

Opioids

  1. Brogly SB, Saab CY. Acute Pain Management in Opioid-Tolerant Patients: A Narrative Review. Pain Ther. 2019 Dec;8(2):249-264.

Corticosteroids

  1. Malatjalian DA. Corticosteroids in pain management: emphasis on epidural injection. Int Anesthesiol Clin. 2008 Spring;46(2):29-49.

Cannabinoids

  1. Tendais I, Snell L, Fernandes L. The pharmacological management of neuropathic pain: an update on drugs approved or under investigation. Expert Opin Pharmacother. 2018 Jul;19(10):1103-1110.
  2. Mehta N, Dasarathy S. Topical Analgesics in Chronic Pain. Med Clin North Am. 2019 May;103(3):447-461.
  3. Smith HS, Darling K. Extended-release opioid analgesics: formulation considerations for prolonged pain relief. Am J Ther. 2011 Jul-Aug;18(4):296-306.

Comparison of Efficacy and Mechanisms

  1. Lynch ME, Campbell F. Cannabinoids for treatment of chronic non-cancer pain; a systematic review of randomized trials. Br J Clin Pharmacol. 2011 Nov;72(5):735-744.
  2. Wallace MJ, Martin BR, Delorenzo RJ. Evidence for a physiological role of endocannabinoids in the modulation of seizure threshold and severity. Eur J Pharmacol. 2000 Sep 22;401(1):29-38.

📗 Note: You might say this diagram has given you a small taste, but the book? It’s the whole brownie. Get baked on knowledge by clicking this link 📗.

Cover of The Doctor-Approved Cannabis Handbook featuring a green medical plus symbol
Unlock the world of medical cannabis with The Doctor-Approved Cannabis Handbook.

Leave a Reply

Your email address will not be published. Required fields are marked *